Keiko Hattori Joins Haemonetics as President of Haemone...( BRAINTREE Mass. and TOKYO Oct. 17...),Health

BRAINTREE, Mass., and TOKYO, Oct. 17 /PRNewswire-FirstCall/ -- Haemonetics Corporation (NYSE: HAE) is pleased to announce that Keiko Hattori will join the Company effective October 22, 2007 as President, Haemonetics Japan. Ms. Hattori will replace Haemonetics Japan's current President, Ryoji Sakai, who previously announced plans to retire.

Brian Concannon, Haemonetics' Chief Operating Officer, said, "Ms. Hattori has tremendous experience and a proven track record for growing businesses in the Japanese and Asian healthcare markets. She brings a depth of leadership to the Japan organization and our senior management team. We are very excited to have someone of her capabilities joining us."

Ms. Hattori's professional background includes positions of increasing responsibility in sales, marketing, and management at several global healthcare companies. She joined Pharmacia in 1985 as Manager of Regulatory Affairs. She remained with Pharmacia when it was acquired by Amersham and ultimately became President of Amersham Biosciences KK. In 2004, when Amersham was acquired by GE she continued the role. Since then Ms. Hattori has held positions with increasing responsibility in various GE divisions in the U.S. and Asia.

Ms. Hattori, age 55, has a BS in Biochemistry from Tokyo University.

Mr. Concannon added, "I'd also like to thank Ryoji Sakai for his significant contributions to Haemonetics during his 13 years of service, as well as for his leadership in transforming our Japanese organization." Mr. Sakai will remain at Haemonetics through fiscal year end as an Executive Advisor to facilitate a smooth transition.

Haemonetics (NYSE: